Table 5.
Comparison of primary tumour and nodal ADCmean and ADCmin values for vROI, aROI, rROI between participants with and without 2 year DFS : HPV OPC and other HNSCC
| Variable |
No 2 year DFS
ADC (10−6 mm2/s) |
2 year DFS
ADC (10−6 mm2/s) |
p-value | ||
|---|---|---|---|---|---|
| Other HNSCC | n | n | |||
| Lymph node vROI ADCmean | 4 | 1071 ± 263 | 10 | 1063 [1091,1358] | 0.73 |
| Lymph node vROI ADCmin | 4 | 923 ± 169 | 10 | 846 ± 206 | 0.77 |
| Lymph node aROI ADCmean | 4 | 1082 ± 289 | 10 | 1101 [962, 1375] | 0.76 |
| Lymph node aROI ADCmin | 4 | 934 ± 174 | 10 | 814 [668, 926] | 0.71 |
| Lymph node rROI ADCmean | 4 | 990 [888, 1059] | 10 | 955 ± 182 | 0.70 |
| Lymph node rROI ADCmin | 4 | 919 ± 168 | 10 | 808 ± 167 | 0.85 |
| Primary tumour vROI ADCmean | 6 | 1128 ± 181 | 13 | 1018 ± 183 | 0.81 |
| Primary tumour vROI ADCmin | 6 | 823 ± 203 | 13 | 789 ± 162 | 0.76 |
| Primary tumour aROI ADCmean | 6 | 1138 ± 179 | 13 | 978 ± 190 | 0.76 |
| Primary tumour aROI ADCmin | 6 | 849 ± 193 | 13 | 776 ± 184 | 0.74 |
| Primary tumour rROI ADCmean | 6 | 1122 ± 224 | 13 | 863 [779, 996] | 0.81 |
| Primary tumour rROI ADCmin | 6 | 836 ± 216 | 13 | 778 ± 182 | 0.66 |
| Variable |
No 2 year DFS
ADC (10−6 mm2/s) |
2 year DFS
ADC (10−6 mm2/s) |
p-value | ||
|---|---|---|---|---|---|
| HPV OPC | n | n | |||
| Lymph node vROI ADCmean | 4 | 938 [872, 1098] | 41 | 1002 [898, 1142] | 0.50 |
| Lymph node vROI ADCmin | 4 | 679 ± 99 | 41 | 814 ± 208 | 0.21 |
| Lymph node aROI ADCmean | 4 | 962 [839, 1052] | 41 | 989 [875, 1150] | 0.50 |
| Lymph node aROI ADCmin | 4 | 761 [607, 820] | 41 | 799[659, 900] | 0.40 |
| Lymph node rROI ADCmean | 4 | 888 ± 114 | 41 | 943 ± 142 | 0.45 |
| Lymph node rROI ADCmin | 4 | 803 ± 187 | 41 | 740 ± 136 | 0.33 |
| Primary tumour vROI ADCmean | 4 | 912 ± 80 | 34 | 960 ± 134 | 0.49 |
| Primary tumour vROI ADCmin | 4 | 862 ± 235 | 34 | 740 ± 136 | 0.56 |
| Primary tumour aROI ADCmean | 4 | 863 ± 74 | 34 | 918 ± 137 | 0.45 |
| Primary tumour aROI ADCmin | 4 | 691 ± 97 | 34 | 725 ± 157 | 0.68 |
| Primary tumour rROI ADCmean | 4 | 793 [737, 904] | 34 | 806 [760, 939] | 0.68 |
| Primary tumour rROI ADCmin | 4 | 673 ± 112 | 34 | 735 ± 171 | 0.49 |
ADC, apparent diffusion coefficient; DFS, diesease free survival; HNSCC, head and neck squamous cell carcinoma; LRFS, locoregional and disease-free survival; OPC, oropharyngeal cancer; ROI, region of interest.
Summary statistics: number (percentage), mean ± standard deviation when normally distributed and median [inter-quartile range] when not normally distributed